Optimizing therapy for mild to moderate IBD
Автор: HMP Education
Загружено: 2018-09-10
Просмотров: 4069
Описание:
Earn CME for related activities: https://www.naccme.com/gastro
In this presentation from the 2018 Mastering Clinical Challenges and Emerging Therapies in IBD conference, Dr. Stephen B. Hanauer discusses best practices for optimizing therapy for mild-to-moderate inflammatory bowel disease (IBD), with a focus on the foundational therapeutic agents, 5-ASA, corticosteroids, and immunomodulators.
© 2018 Imedex, LLC.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: